Mergers and Inquisitions

NOVEMBER 1, 2023

When you hear the words “healthcare private equity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector? In most of the world, healthcare is either government-run or a mixed public/private sector. Are there many private healthcare companies for PE firms to acquire?

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

Sun Acquisitions

AUGUST 5, 2024

In the dynamic world of mergers and acquisitions (M&A), staying ahead of the curve is crucial for success. As a result, ESG criteria are being integrated into due diligence processes, investment evaluations, and post-merger integration strategies.

M&A 59

M&A Mergers and Acquisitions IPO Valuation 59

Cooley M&A

OCTOBER 29, 2020

is the increased frequency at which SPAC IPOs are occurring. As reflected in Chart 1 , 102 SPAC IPOs have been announced this year as of September 18, 2020—almost double the number of SPAC IPOs in all of last year (and more than double the number of SPAC IPOs in 2018). SPAC vs. IPO. A distinct feature of SPAC 3.0

M&A 52

M&A IPO Valuation Mergers and Acquisitions 52

Mergers and Inquisitions

OCTOBER 18, 2023

But in capital markets, you work on just one category of deals , such as equity-related transactions (IPOs, follow-ons, convertible bonds, etc.) Note that while Leveraged Finance is technically in “capital markets,” it is closer to groups like M&A because most of the work relates to funding for acquisitions and leveraged buyouts.

Investment Banking 59

Investment Banking Capital Market Recruitment Capital 59

Mergers and Inquisitions

MARCH 13, 2024

This style is about purchasing minority stakes in cash-flow-negative-but-high-growth companies that want to scale and eventually go public or sell (think: Uber or Airbnb before their IPOs). Many of these firms use debt to fund deals, and they complete bolt-on acquisitions for portfolio companies. Developing new products or services.

Private Equity 105

Private Equity Equities Capital Portfolio 105

Cooley M&A

JANUARY 23, 2024

For example, in the biopharma space, AbbVie, Bristol Myers Squibb, AstraZeneca, and Roche each announced multiple big-ticket acquisitions in the fourth quarter – including Abbvie’s acquisition of ImmunoGen for $10.1 billion; Bristol Myer Squibb’s acquisition of RayzeBio for $4.1 billion and Cerevel Therapeutics for $8.7

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52

Mergers and Inquisitions

JULY 31, 2024

Morgan’s acquisition of Carnegie Steel in 1901 – was an industrials private equity deal. billion acquisition of Veritiv , a B2B provider of packaging products and services and print-based products: The deal was done at a 4.7x These multiples might seem ridiculously low if you’re used to tech or healthcare deals.

Private Equity 66

Private Equity Equities Middle Market Debt 66